Literature DB >> 19049641

Idiopathic CD4 lymphocytopenia and opportunistic infection--an update.

Ling Luo1, TaiSheng Li.   

Abstract

A severe CD4 T-cell depletion predisposes humans to opportunistic infections. In recent years, reports of cases of opportunistic infections caused by CD4 T-cell depletion without HIV infection have been accumulating. Such cases, termed idiopathic CD4 T lymphocytopenia (ICL), are very rare. The epidemiologic data do not suggest that the condition is caused by a transmissible agent. Unlike HIV infection, the decrease in the CD4 cell counts of patients with ICL is often slow. The clinical spectrum of ICL ranges from an asymptomatic laboratory abnormality to life-threatening opportunistic infections. However, the pathogens, clinical significance and treatment of ICL patients still await systematic research. This review summarizes the current knowledge of the poorly understood syndrome of idiopathic CD4 lymphocytopenia, providing key insights into the pathogenesis and immunologic characteristics, and suggesting approaches to enhance CD4 T-cell counts.

Entities:  

Mesh:

Year:  2008        PMID: 19049641     DOI: 10.1111/j.1574-695X.2008.00490.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  13 in total

1.  Giardiasis: a malignant mimicker?

Authors:  Ozdemir Kanar; Rahman Nakshabendi; Faiz Jiwani; Yuzhou Liu; William Allsopp; Andrew C Berry
Journal:  Intern Emerg Med       Date:  2015-06-09       Impact factor: 3.397

2.  Defective T cell chemotaxis to sphingosine 1-phosphate and chemokine CCL21 in idiopathic T lymphocytopenia.

Authors:  Edward J Goetzl; Janice B Schwartz; Mei-Chuan Huang
Journal:  J Clin Immunol       Date:  2011-06-14       Impact factor: 8.317

3.  Cryptococcal rib osteomyelitis as primary and only symptom of idiopathic CD4 penia.

Authors:  Rebecca A Legarth; Merete Christensen; Henrik Calum; Terese L Katzenstein; Jannik Helweg-Larsen
Journal:  Med Mycol Case Rep       Date:  2014-02-25

4.  Difficulty diagnosing chronic cryptococcal meningitis in idiopathic CD4+ lymphocytopenia.

Authors:  Giuseppe Sancesario; Giampiero Palmieri; Gemma Viola; Carla Fontana; Alessandra Perfetti; Lucia Anemona; Roberto Floris; Simone Marziali; Giorgio Bernardi; Luigi Giusto Spagnoli
Journal:  Neurol Sci       Date:  2011-03-08       Impact factor: 3.307

5.  Motor Axonal Neuropathy Associated With Idiopathic CD4(+) T-Lymphocytopenia.

Authors:  Tae Im Yi; Bo Ra Kim; In Soo Han; Bo Kyoung Kim
Journal:  Ann Rehabil Med       Date:  2013-02-28

6.  Case study documenting the diagnosis of idiopathic CD4+ Lymphocytopenia in a patient with atypical fungal infection (disseminated blastomycosis) by FNA of adrenal mass.

Authors:  Richard H Siderits; Osman Ouattara; Alan Marcus; Hong Guang Gao; Hong Bing Deng; Janusz Godyn
Journal:  Cytojournal       Date:  2010-08-05       Impact factor: 2.091

7.  Syndrome of selective IgM deficiency with severe T cell deficiency associated with disseminated cutaneous mycobacterium avium intracellulaire infection.

Authors:  Asal Gharib; Ankmalika Gupta Louis; Sudhanshu Agrawal; Sudhir Gupta
Journal:  Am J Clin Exp Immunol       Date:  2015-10-12

8.  Severe Pneumocystis jirovecii pneumonia in an idiopathic CD4+ lymphocytopenia patient: case report and review of the literature.

Authors:  Bernabé F F Chumpitazi; Pierre Flori; Jean-Baptiste Kern; Marie-Pierre Brenier-Pinchart; Sylvie Larrat; Clémence Minet; Laurence Bouillet; Danièle Maubon; Hervé Pelloux
Journal:  JMM Case Rep       Date:  2014-12-01

9.  Probable disseminated Mycobacterium abscessus subspecies bolletii infection in a patient with idiopathic CD4+ T lymphocytopenia: a case report.

Authors:  Claudia Colomba; Raffaella Rubino; Paola Di Carlo; Caterina Mammina; Celestino Bonura; Lucia Siracusa; Lucina Titone; Laura Saporito
Journal:  J Med Case Rep       Date:  2012-09-04

10.  Idiopathic CD4 lymphocytopenia with sensorimotor polyneuropathy.

Authors:  Vinod Puri; Ashish Kumar Duggal; Neera Chaudhry
Journal:  Ann Indian Acad Neurol       Date:  2016 Jul-Sep       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.